Stuart Peters News Today

Frazier Life Sciences Management L.P. boosted its stake in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 33.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,401,704 shares of the biopharmaceutical company’s stock after purchasing an additional […]

Bellevue Group AG raised its stake in MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,953,313 shares of the biopharmaceutical company’s stock after acquiring an additional 150,000 shares during the quarter. MacroGenics comprises approximately […]

Bellevue Group AG raised its stake in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 9,953,313 shares of the biopharmaceutical company’s stock after buying an additional 150,000 shares during the period. MacroGenics comprises approximately 1.5% of Bellevue Group AG’s investment portfolio, making the […]

B. Riley initiated coverage on shares of MacroGenics (NASDAQ:MGNX – Free Report) in a research note published on Friday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $25.00 price objective on the biopharmaceutical company’s stock. A number of other brokerages also recently issued reports on MGNX. TD Cowen raised shares of […]

JMP Securities restated their market outperform rating on shares of MacroGenics (NASDAQ:MGNX – Free Report) in a research report report published on Thursday, Benzinga reports. A number of other research firms have also recently commented on MGNX. BTIG Research boosted their price target on shares of MacroGenics from $12.00 to $24.00 and gave the stock […]

GSA Capital Partners LLP increased its position in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 74.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 225,918 shares of the biopharmaceutical company’s stock after buying an additional 96,760 shares during the […]

The brand is now stocked at the Mandarin Oriental, Emirates Palace Abu Dhabi, Conrad and Five Jumeirah Village Hotel in Dubai.

It’s not really clear about what exactly happened or why anyone should care about it 15 years later.

StockNews.com upgraded shares of MacroGenics (NASDAQ:MGNX – Get Rating) from a hold rating to a buy rating in a research report report published on Friday. Several other analysts also recently commented on the company. Citigroup increased their price objective on MacroGenics from $7.00 to $8.00 in a research note on Monday, March 20th. Stifel Nicolaus […]

MacroGenics (NASDAQ:MGNX – Get Rating) had its target price hoisted by JMP Securities from $8.00 to $10.00 in a research report sent to investors on Thursday morning, The Fly reports. MGNX has been the topic of a number of other research reports. Citigroup boosted their price target on shares of MacroGenics from $7.00 to $8.00 […]